← Back to Search

Behavioural Intervention

Peer Partnerships for Methamphetamine-Associated Heart Failure (PEER-Heart Trial)

N/A

Recruiting

Led By Brian Chan, MD, MPH

Research Sponsored by Oregon Health and Science University

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

No client-reported diagnosis of heart failure

Age 18 years or older

Must not have

Actively taking medications for heart failure

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 6 months

Awards & highlights

No Placebo-Only Group

Summary

"This trial aims to test if training community members to screen for heart problems caused by methamphetamine use in rural areas is possible and effective in helping people get the right medical care."

Who is the study for?

This trial is for individuals in rural areas who use methamphetamine and may have heart failure linked to drug use. They should be willing to undergo screening and follow-up care via telehealth with a cardiology specialist.

What is being tested?

The study is testing if having community peers help with screening for heart issues caused by methamphetamine, plus getting cardiology care through telehealth, can work well in rural settings.

What are the potential side effects?

Since the interventions involve standard treatment and remote health services rather than medications, there are no direct side effects like you'd expect from drugs. However, participants might experience technical difficulties or privacy concerns with telehealth.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I have never been diagnosed with heart failure.

Select...

I am 18 years old or older.

Select...

I may have heart issues related to methamphetamine use, indicated by specific heart tests.

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:

Select...

I am currently on medication for heart failure.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 6 months

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~6 months

This trial's timeline: 3 weeks for screening, Varies for treatment, and 6 months for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.

Primary study objectives

Linkage to cardiology care

Secondary study objectives

Goal Directed Medical Therapy (GDMT) prescribed

Linkage to diagnostic echocardiogram

Awards & Highlights

No Placebo-Only Group

All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups

Experimental Treatment

Active Control

Group I: Peer-Supported Telehealth CardiologyExperimental Treatment1 Intervention

Participants will receive a virtual consultation with a cardiovascular specialist, referral for a locally performed echocardiogram (ECG), and transitional care management facilitated by a remote nurse care manager and the peer to treat the participants heart failure.

Group II: Peer-supported Treatment as UsualActive Control1 Intervention

Participants will receive a peer-supported referral to a local primary care provider who will create a plan to treat the participants heart failure.

0 / 4Eligibility criteria met